22nd Century Group Acquires RX Pharmatech, Files U.S. Drug Master File For CBD API, Teams Up With Transo-Pharm
22nd Century Group, Inc. (NASDAQ: XXII) announced the acquisition of privately held RX Pharmatech Ltd, a United Kingdom distributor of cannabinoids with 1,276 novel food applications with the U.K. Food Standards Agency (FSA).
